Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

GLP-1 drugs first helped people manage Type 2 diabetes. Today, doctors also use them widely for weight loss. Researchers are now exploring whether these medications could also affect breast cancer risk and outcomes. Early studies suggest that GLP-1 drugs may…

Weight regain after bariatric surgery happens more often than most people expect. Even years after a successful procedure, the pounds can creep back. That’s why many doctors now reach for a newer tool: GLP-1 receptor agonist medications. Semaglutide, sold under…

Novo Nordisk is looking into whether smaller doses of its Wegovy pill can still help people lose weight. A new clinical trial kicked off on August 12, and it’s already drawing attention across the pharmaceutical world. The study will follow…

Pumpkin spice season looks a little different this year at Smoothie King. The chain just rolled out a smoothie made specifically for people taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Smoothie King calls it the Slim-N-Trim GLP-1 Pumpkin Smoothie,…

Nestlé has started using artificial intelligence to build food and supplement products for people taking weight loss drugs like Wegovy and Mounjaro. The company confirmed this to Reuters. In fact, the approach says a lot about where the food industry…

TikTok has a fake weight loss drug problem, and it’s hitting women the hardest. A new report from the gender-justice group UltraViolet found more than 200 accounts on the platform that appeared to break TikTok’s own rules. These accounts were…

The growing use of GLP-1 weight-loss medicines is changing more than just body weight. Doctors and aesthetic specialists are seeing more patients who notice changes in their face after losing a large amount of weight. As a result, demand for…

Can a weight-loss injection change your career prospects? For unemployed women, the answer increasingly looks like yes. A new study from Harvard economist Rebecca Diamond found something striking. Women who started taking GLP-1 medications while unemployed saw their odds of…

Eli Lilly wants the black market for one of its most promising obesity drugs shut down, and it’s turning to the courts to make that happen. The company announced six new lawsuits this week. Each one targets a business accused…

Novo Nordisk has a new media partner. The drugmaker just named Omnicom as its agency of record for advertising, ending a six-year run with WPP that started back in 2020. The switch comes at a busy moment for the company.…